Ikarian Capital LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:30 pm Sale |
2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 394,536 3.000% |
-420,828 (-51.61%) |
Filing |
| 2021-02-16 07:49 am Purchase |
2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 815,364 6.300% |
30,000 (+3.82%) |
Filing |
| 2020-12-30 5:26 pm Purchase |
2020-12-15 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 785,364 6.100% |
785,364 (New Position) |
Filing |